WELL Health Technologies Corp. conducted a bought deal private placement offering, including the exercise in full of the underwriters’ overallotment option. The offering involved the underwritten private placement of a total of C$10.5-million aggregate principal amount senior unsecured convertible debentures of WELL Health (at a price of $1,000 per convertible debenture).
Fasken advised WELL Health with a team led by Mike Stephens (Corporate Finance & Securities), and included Shahrooz Nabavi (Corporate Finance), Shanlee von Vegesack (Corporate Finance & Securities), Gosia Piasecka (Corporate Finance & Securities) and Myriam Gonzalez (Corporate Finance & Securities).
